Skip to Content

Ocrevus - Are most insurance carriers approving this medicine ?


suzanne66 29 May 2017

The FDA has approved Ocrevus (ocrelizumab) for the treatment of adults with primary progressive MS and with relapsing MS.
List cost is $65,000 per year so access will depend on individual insurance plans.
For people who qualify, Genentech plans to offer patient assistance programs through Genentech Access Solutions: (866) 4ACCESS/(866) 422-2377 or

Votes: +0
streetstock14 18 Mar 2020

I want to know if medicare and blue cross covers this for people over 65

Votes: +0 free discount card

Further Information

Similar Questions

Saxenda - What insurance carriers cover this RX?

What types of MS does Ocrevus treat?

How does Ocrevus work for MS?

How long does an Ocrevus infusion take?

How long does it take Ocrevus to work?

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.